Researchers are calling for the application of locally driven strategies, supported by stronger regional evidence, to improve early cancer detection and precise care.

Medical oncologist Dr. R. Julie Brahmer discusses biomarker testing and advanced treatment for lung cancer patients.

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the odds of a tumor developing. By Nina Agrawal Scientists have made a discovery ...

Add Yahoo as a preferred source to see more of our stories on Google. A total of 10,678 cases have been detected since the programme began in 2019 - Prapass Pulsub/Moment RF More than 10,000 people in ...

Lung cancer remains the leading cause of cancer-related mortality worldwide despite advances in early detection and treatment. Furthermore, its epidemiology has undergone a profound transformation, ...

A urine test developed by scientists at the University of Cambridge has moved a step closer to clinical use following new findings revealing it could do more than first thought. Originally designed to ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Please provide your email address to receive an email when new articles are posted on . Less than half of older adults with metastatic lung cancer received systemic treatment. Findings underscore the ...

A new artificial intelligence tool called Sybil is helping doctors predict lung cancer risk years before it appears on scans, potentially closing gaps in current screening guidelines. Standard lung ...